Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-iminobiotin dose-escalation safety and pharmacokinetics study in healthy male volunteers
NL-OMON35086Active, not recruiting
- Sponsor
- Neurophyxia
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of 2-iminobiotin in asphyxia neonatorum, sponsored by Neurophyxia. Primary endpoints: Plasma concentrations of 2-iminobiotin, Pharmacokinetic parameters in plasma and urine and 6 more. Started Dec 2009; status: active, not recruiting.
02
Drugs
2-iminobiotin
03
Conditions
asphyxia neonatorum
Beyond the preview
Go deeper on NL-OMON35086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35086.